Callan JMB Inc. provides integrative logistics services for healthcare organizations and emergency management agencies, including fulfillment, storage, monitoring, cold-chain logistics and specialized distribution. Company updates commonly address emergency preparedness contracts, reverse distribution of vaccines and pharmaceuticals, regulated product handling, government relationships and business updates tied to healthcare supply-chain resilience.
Recurring developments also include the Atlas Complex in Marion, Alabama, a medical, pharmaceutical and logistics campus supporting QA/QC, cold-chain logistics, warehousing and domestic distribution. Other updates cover pharmaceutical onshoring initiatives, independent manufacturing oversight, quality-control governance, collaboration activity with life-sciences partners, financial results, investor communications and legal or listing-related corporate matters.
Callan JMB (NASDAQ: CJMB) announced that its management team will participate in the LD Micro Main Event XIX on October 19-21, 2025. Presentation is scheduled for October 21, 2025 at 12:00 PM PT at Hotel del Coronado, San Diego, CA. A live webcast will be available at https://ldmicrocasts.com/. For access or questions, contact your LD Micro representative or email CallanJMB@kcsa.com.
Callan JMB (NASDAQ: CJMB), a healthcare logistics services provider, has announced its participation in two upcoming investment conferences in September 2025. The company will present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10 at the Lotte New York Palace Hotel, with an on-demand presentation available from September 5.
Additionally, management will participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference on September 16-17, presenting at 10:30 a.m. ET. The company will conduct one-on-one investor meetings during both conferences.
[]Callan JMB (NASDAQ: CJMB), a healthcare logistics company, reported Q2 2025 financial results and significant business developments. The company recorded Q2 revenues of $1.7 million and a net loss from operations of $1.4 million.
Key developments include a strategic partnership with Revival Health for integrated supply chain services, launch of an Indian subsidiary with planned temperature-controlled facilities in Pune, and extension of Chicago's emergency preparedness contract through June 2026 with a $1.5 million funding increase to $9.1 million total. The company also appointed Christopher Shields as SVP of Emergency Preparedness & Response and successfully managed a measles outbreak response.
Post-quarter, Callan JMB secured a $25 million equity line of credit to support growth initiatives in GLP-1 pharmaceutical distribution, specialty compounding pharmacy logistics, and premium food packaging solutions.
Callan JMB (NASDAQ: CJMB) has secured a contract extension with the City of Chicago through June 2026, marking a significant development in their seven-year partnership. The contract, focused on Health Preparedness Supplies and Related Services, includes a $1.5 million funding increase, bringing the total contract value to $9.1 million.
Through its subsidiary Coldchain Technology Services, Callan JMB will continue providing pallet storage and emergency supplies management services for Chicago residents. The extension ensures uninterrupted service delivery in emergency preparedness and response capabilities.
Callan JMB (NASDAQ: CJMB) has established a new subsidiary, Callan JMB Services (India) Private Limited, to expand its logistics services in India. The company plans to open a temperature-controlled warehouse in Pune, Maharashtra capable of storing pharmaceuticals at various temperatures, including -80°C for tissue samples.
The subsidiary, incorporated on June 20, 2025, will facilitate pharmaceutical distribution within India and help Indian companies establish manufacturing operations in the U.S. The company has already secured an agreement with Walker's Pharmaceuticals and is collaborating with Brihans Natural Products for U.S. manufacturing setup and distribution services.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics company, has announced its participation in Maxim Group's 2025 Virtual Tech Conference. The company will engage in a fireside chat on June 3, 2025, at 10:30 a.m. ET. The conference, themed "Discover the Innovations Reshaping Tomorrow," will run from June 3-5, 2025.
Callan JMB specializes in fulfillment, storage, monitoring, and cold chain logistics services for the healthcare industry and emergency management agencies. Interested parties can register through the provided link or contact KCSA Strategic Communications for meetings.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics company, reported its Q1 2025 financial results following its February IPO. The company raised $5.7 million through its IPO at $4.00 per share. Q1 2025 financial results showed revenue of $1.45 million, with a gross profit margin of 42.5%, but reported a net loss of $1.2 million due to increased SG&A expenses and declining emergency preparedness service demand.
Key developments include appointing Christopher Shields as SVP of Emergency Preparedness & Response, renewing contracts with Texas DSHS, securing a five-year contract with Oregon Health Authority, and launching a vaccine management lease program. The company is expanding into GLP-1 pharmaceutical transportation, specialized compounding pharmacy logistics, and premium food packaging services.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics services provider, has announced its upcoming participation in the Aegis Capital Corp. Virtual Conference scheduled for May 21, 2025. The company's management team will deliver a presentation at 1:00 p.m. ET. Callan JMB specializes in fulfillment, storage, monitoring, and cold chain logistics services for the healthcare industry and emergency management agencies.